Daily Stock List
VGambling, Inc. (GMBL)
Real Pennies reported previously on VGambling, Inc. (GMBL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
VGambling, Inc. is a next generation online gambling company specifically centered on eSports. The Company’s intention is to offer wagering on eSports events on a fully licensed, regulated, and secured platform to the international eSports audience, excluding the U.S. A team of industry and technical experts from the online gambling and video game industries, e-Sports, marketing, legal and financial professionals lead VGambling. OTCQB-listed, VGambling has offices in St. Mary's, Antigua and Barbuda.
Furthermore, the Company’s intention is to offer users globally the ability to participate in multi-player video games tournaments online for cash prizes. At present, VGambling is developing a number of play money websites and its real money wagering website.
The Company has been issued a Client Provider Authorization Permit by the Kahnawake Gaming Commission. VGambling has applied for an Interactive Wagering License with the Financial Services Regulatory Commission of Antigua and Barbuda to conduct real money interactive gaming on a worldwide basis from bases in Canada and Antigua.
The Company has entered into a Betting Gaming Platform Software Agreement with Swiss Interactive Software GmbH to provide wagering platform software. Moreover, it has an agreement with CAMS, LLC to provide worldwide electronic payment and risk management solutions. VGambling has a peer-to-peer wagering system. It will offer real money betting exchange style wagering on all professional eSports events.
In August of 2016, VGambling announced an agreement with Income Access. With this agreement, the Company will integrate Income Access' award-winning affiliate management platform and Ad Serving tool to manage the operator's affiliate programme.
Income Access is a technology and digital marketing enterprise serving the international iGaming industry. It is based in Montreal, Quebec, and has offices in Vancouver, British Columbia, the United Kingdom, and Australia.
VGambling has appointed Mr. David George Atmore Watt, FCCA as a Member of the Board of Directors of the Company. Mr. Watt, FCCA, is a Fellow of the Chartered Association of Certified Accountants of the UK. He is a Chartered Certified Accountant and a Member of the Institute of Chartered Accountants of the Eastern Caribbean.
Mr. Watt has over 25 years of finance, accounting, as well as senior management experience. Most recently, he was Financial Controller for the Blue Waters Hotel and Caribbean Developments (ANU) Ltd., in Antigua.
VGambling, Inc. (GMBL), closed Wednesday's trading session at $0.35, up 12.90%, on 2,107 volume with 1 trade. The average volume for the last 60 days is 1,506 and the stock's 52-week low/high is $0.17/$0.40.
Immage Biotherapeutics Corp. (IMMG)
We are reporting on Immage Biotherapeutics Corp. (IMMG) today, here at the QualityStocks Daily Newsletter.
Immage Biotherapeutics Corp. is an early-stage biotechnology company listed on the OTC Markets Group’s OTCQB. It was established in 2015 to harness the power of the human immune system to treat cancer. The Company is developing manifold viable candidates to treat triple-negative breast cancer (TNBC). Immage Biotherapeutics has progressed from in-vitro trials to animal testing. The Company has offices in Bethesda, Maryland, and Philadelphia, Pennsylvania, and it’s a subsidiary or PepVax, Inc.
Immage Biotherapeutics has a method that permits the fast development of key cancer immunotherapy candidates. These could be licensed to the biotechnology and pharmaceutical industry, giving them the opportunity to develop in vitro proven treatments, establishing credibility of the Company’s rapid development model.
Immage Biotherapeutics’ Co-Founder, Dr. Anton Dormer, is a top expert in peptide design and protein development by way of computational biology. He developed bioinformatics tools for cancer drug development. In addition, Co-Founder Mr. Mahesh Narayanan is an experienced entrepreneur in the field of biotechnology. He leads the business development strategies for the Company.
Immage develops targeted therapeutics for the treatment of tumors that expresses the Melanoma antigen family – A (MAGE-A) antigen. This increasing portfolio of treatment targets using one universal vaccine gives it the advantage of concentrating on tumors, which have not had viable treatments and yet decreases cost as it is one therapy.
The Company’s pipeline is built from a proprietary immunotherapy that can be used alone and in strategic combinations to develop novel, disease-specific therapies that enhance the body's immune response to treat cancers.
The MAGE-A antigen is a cancer test expressed within the human testes. It is highly immunogenic. It has been considered as a viable target for the development of immunotherapies of tumors overexpressing the MAGE-A family of antigens. The MAGE-A sub-family of cancer testis antigen is expressed in germ cells, however not exclusively.
In October of 2015, Immage Biotherapeutics commenced in vitro verification experiments for efficacy. In January 2016, the Company announced the addition of new candidates to the pipeline, while advancing 8 candidates into final in vitro trials for testing of expression. In June of 2016, Immage successfully completed its in vitro trials and started designing in vivo studies. Subsequently, it moved two more candidates into in vivo trials.
Immage Biotherapeutics Corp. (IMMG), closed Wednesday's trading session at $0.929, up 85.87%, on 221,831 volume with 117 trades. The average volume for the last 60 days is 2,676 and the stock's 52-week low/high is $0.10/$0.50.
FreeSeas, Inc. (FREEF)
We are highlighting FreeSeas, Inc. (FREEF) today, here at the QualityStocks Daily Newsletter.
FreeSeas, Inc., via its subsidiaries, provides drybulk shipping services. Incorporated in the Marshall Islands, FreeSeas is a foremost, global commercial shipping enterprise transporting iron ore, coal, grain, steel products and other drybulk cargoes along international shipping routes. The Company is also an owner of a controlling stake in a company commercially operating tankers.
The Company formerly went by the name Adventure Holdings S.A. It changed its corporate name to FreeSeas, Inc. in April 2005. FreeSeas is based in Athens, Greece. The Company’s shares trade on the OTC Markets Group’s OTCQB.
FreeSeas operates two Handysize vessels. The Company said that its investment and operational focus has been in the Handysize sector (generally defined as less than 40,000 dwt of carrying capacity) and the Handymax sector (generally defined as between 40,000 dwt and 60,000 dwt).
FreeSeas believes Handysize and Handymax vessels are more versatile in the types of cargoes they can carry and trade routes they can follow, and offer less volatile returns than larger vessel classes. The Company also believes this segment offers better demand and supply demographics than other drybulk asset classes.
FreeSeas (under spot charters) pays voyage expenses including port, canal, and fuel costs. Under period time charters, the “charterer” pays the voyage expenses. Under spot charters and period time charters, FreeSeas is responsible for vessel operating expenses. These expenses include crew costs, provisions, deck and engine stores, lubricating oil, insurance, maintenance, as well as repairs.
In addition, the Company is responsible for each vessel's intermediate drydocking and special survey costs. The exception to this practice is called a "bareboat contract". This is where the charterer is responsible for the vessel's maintenance and operations, and all voyage expenses.
FreeSeas earlier announced that on September 26, 2016, it sold to unrelated third parties the M/V ‘Free Maverick’, for a sale price of $1,925,000. Her mortgage was discharged. The M/V ‘Free Maverick’ is a 1998-built, 23,994 dwt Handysize dry bulk carrier.
Last month, FreeSeas announced the results of its Annual Meeting of Shareholders held on December 22, 2016. Selected highlights of the meeting include the shareholders electing Mr. Dimitris Papadopoulos to the Board of Directors for a three year term; ratifying the appointment of RBSM LLP, as FreeSeas independent registered public accounting firm for the fiscal year ending December 31, 2016; and granting discretionary authority to its Board to amend the Amended and Restated Articles of Incorporation of the Corporation to effect one or more consolidations of the issued and outstanding shares of common stock, and ascertain whether to arrange for the disposition of fractional interests by shareholder entitled thereto.
FreeSeas, Inc. (FREEF), closed Wednesday's trading session at $0.0002, even for the day, on 111,491,642 volume with 64 trades. The average volume for the last 60 days is 52,272,642 and the stock's 52-week low/high is $0.0002/$3.00.
Diego Pellicer Worldwide, Inc. (DPWW)
We are highlighting Diego Pellicer Worldwide, Inc. (DPWW), here at the QualityStocks Daily Newsletter.
Diego Pellicer Worldwide, Inc. is a real estate and consumer retail development company based in Seattle, Washington. It concentrates on developing the Company as the world’s first "premium" marijuana brand. Diego Pellicer does not grow or sell marijuana or marijuana infused products. The Company’s tenants are stand-alone, independent businesses and Diego Pellicer Worldwide has no ownership in them. Diego Pellicer Worldwide lists on the OTCQB.
Via the development and acquisition of premium, legally compliant real estate locations for cannabis growers and retailers, the Company provides a best-in-class platform for new business growth in the cannabis industry. Fundamentally, Diego Pellicer Worldwide leases legally compliant locations for growing, retailing, or the medical dispensing of marijuana. In addition, it participates in the profit of café operations of non-infused products; participates in the profit of ancillary products, including branded apparel; and in some instances, it signs contracts with its tenants, with the right to acquire at its discretion. Diego Pellicer has secured numerous first-rate locations in Colorado, Washington and Oregon.
The Company’s initial focus is to acquire and develop legally compliant real estate locations for the purposes of leasing them to State licensed companies in the cannabis industry. Its initial revenues originate from leasing real estate and selling non-cannabis related products. However, when it is federally legal to do so, Diego Pellicer said it will be properly positioned to take advantage of pre-negotiated acquisition contracts with selected Diego Pellicer tenants in marijuana retail and production facilities throughout the country.
Diego Pellicer Worldwide has leased two facilities to grow operators in Denver, Colorado. The grow facilities are licensed for medical and recreational cannabis. These facilities are in excess of 30,000 sq. ft.
Diego Pellicer Worldwide earlier announced its first flagship store tenant, Diego Pellicer Washington (3,000 sq. ft. space), passed its final inspection for retail marijuana sales and began operations in Q4 2016. This flagship store features high-end cannabis product and accessories. These include flower, waxes, and edibles, and state-of-the-art ancillary products, such as glassware, vaporizers, grinders, and torches.
In September of 2016, Diego Pellicer Worldwide, and branded tenant Diego Pellicer Washington announced opening Seattle's first quality cannabis store. The luxury marijuana store opened on Friday, October 7, 2016.
Diego Pellicer Worldwide is named after the risk-taking pioneer, Diego Pellicer. He was a business and political leader among the island of Cebu in the Philippines. Diego Pellicer invested his fortunes in hemp while others invested in the spice trade. A sugar crisis bankrupted many on the island. This lead to the Spanish-American War in 1898. Diego Pellicer emerged as the largest hemp producer globally. Today, his great-grandson acts as the Co-Founder. He is proud to pay homage to his great-grandfather.
Diego Pellicer Worldwide, Inc. (DPWW), closed Wednesday's trading session at $0.30, up 25.00%, on 42,583 volume with 18 trades. The average volume for the last 60 days is 27,506 and the stock's 52-week low/high is $0.20/$1.00.
Great Basin Scientific, Inc. (GBSN)
Epic Stock Picks, Wolf of Penny Stocks, StreetInsider, Trader Power News, MarketClub Analysis, BUYINS.NET, The Weekly Options Trader, Jason Bond, Promotion Stock Secrets, Stock Beast, StockOodles, InvestorsUnderground, PennyPro, and Investing Futures reported earlier on Great Basin Scientific, Inc. (GBSN), and we are reporting on the Company as well, here at the QualityStocks Daily Newsletter.
Great Basin Scientific, Inc. is a molecular diagnostics company based in Salt Lake City, Utah. Its mission is to quickly and accurately diagnose, reduce misdiagnoses, and considerably limit the spread of infectious disease. The Company commercializes ground-breaking chip-based technologies. Its devotion is to the development of simple, yet strong, sample-to-result technology and products that provide fast, multiple-pathogen diagnoses of infectious diseases.
The Company’s diagnostic system empowers health providers with accurate and timely information. This information is for diagnosing infectious disease. This permits health providers to appropriately treat patients to improve outcomes and support antimicrobial stewardship. This results in shorter hospital stays and money saved.
Great Basin Scientific’s sample-to-result molecular diagnostics are fully automated with few hands-on steps. Depending on the target of interest, results are in 120 minutes or less. Moreover, sample-to-result molecular diagnostics feature on-demand testing. There is no upfront analyzer cost. Also, sample-to-result molecular diagnostics multiplexes up to 64 distinct targets in a single assay for more answers.
The Company’s diagnostic system uses an integrated disposable cartridge containing all essential reagents. It also uses an inexpensive bench-top analyzer. This analyzer executes the assay, interprets the results, and provides electronic output to the clinician. The user-friendly tests deliver more diagnostic data per sample.
Great Basin Scientific has four commercially available assays: The Staph ID/R Blood Culture Panel, Shiga Toxin Direct Test, Group B Streptococcus (GBS) Test, and the Toxigenic Clostridium difficile (C. diff) Test. Furthermore, it has five additional tests and panels in the development phase: Nasal S. aureus Pre-Screen, Candida Blood Infections Panel, Stool Bacterial Pathogens Panel, CT/NG Test, and Bordetella Direct Test.
Great Basin Scientific earlier announced the U.S. and European commercial launch of its Staph ID/R Blood Culture Panel. This is its first multiplex panel. This sample-to-result, automated panel benefits hospitals and laboratories through detecting, in about two hours, bloodstream infections caused by MRSA and other Staphylococcus species. This permits accurate, timely, and cost-effective diagnosis and treatment of patients.
Last month, Great Basin Scientific announced the 510(k) submission for the Stool Bacterial Pathogens Panel to the U.S. Food and Drug Administration (FDA). Upon expected clearance, this syndromic panel for the identification of bacterial causes of acute gastroenteritis will be its second multiplex panel in its increasing menu of sample-to-result assays to diagnose infectious disease. Additionally, Great Basin Scientific is seeking CE marking for the panel.
Today, Great Basin Scientific announced the completion of the clinical trial and 510(k) submission to the FDA of its Bordetella Direct Test. Its sample-to-result test detects Bordetella pertussis directly from the patient specimen, identifying the bacterium behind the highly-contagious respiratory disease usually called whooping cough. Great Basin Scientific is also seeking a CE mark for this test.
Great Basin Scientific, Inc. (GBSN), closed Wednesday's trading session at $0.0024, up 33.33%, on 318,852,813 volume with 1,533 trades. The average volume for the last 60 days is 11,347,525 and the stock's 52-week low/high is $0.0016/$921.20.
The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX). Today, ChineseInvestors.com closed trading at $1.95, off by 6.70%, on 2,107 volume with 1 trade. The stock’s average daily volume over the past 60 days is 1,506 and its 52-week low/high is $0.17/$0.40.
ChineseInvestors.com, Inc. The interview outlining CIIX’s current business strategy and future plans can be heard at http://smallcapvoice.com/blog/1-30-17-smallcapvoice-interview-with-chineseinvestors-com-inc-ciix.In the interview, Klitenic provides insight into ChineseInvestor.com’s strategy to expand its existing business model and enter into the cannabis industry in China. While marijuana use is illegal in China, consumer demand for cannabis-based oils – which are legal – continues to grow, creating tremendous market opportunity in a population of more than 1 billion people.
Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.
Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.
At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.
CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.
The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.
Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world's first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer's disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.
In conjunction, CIIX's cannabis-focused "Yelp"-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. Disclaimer
ChineseInvestors.com Featured in New Interview with SmallCapVoice.com
ChineseInvestors.com, Inc. to Present at NobleCon13 Annual Investor Conference
ChineseInvestors.com, Inc. (CIIX) Engages NetworkNewsWire for Corporate Communications Solutions
National Waste Management Holdings, Inc. (NWMH)
The QualityStocks Daily Newsletter would like to spotlight National Waste Management Holdings, Inc. (NWMH). Today, National Waste Management Holdings, Inc. closed trading at $0.098045, up 2.40%, on 4,300 volume with 3 trades. The stock’s average daily volume over the past 60 days is 24,712, and its 52-week low/high is $0.06/$1.15.
National Waste Mgmt. Holdings, Inc. today announces immediate growth opportunities through its acquisition of Northeast Data Destruction and Recycling, LLC. With this acquisition, which closed December 31, 2016, National Waste's reach in upstate New York now extends south to Kingston, New York, where Northeast Data Destruction and Recycling offers cardboard recycling and document destruction, hard drive destruction, and other data destruction. Implementing its existing services offered in other areas, National Waste will grow its new Kingston operation to also include roll-off services.
National Waste Management Holdings, Inc. (NWMH) is a solid waste management company offering comprehensive solutions for full waste diversion along Florida's west coast and in upstate New York. With an established base of long-term partnerships with municipal, institutional, commercial and industrial customers, along with a successful acquisition strategy, National Waste has set its course to become a leading waste diversion company.
National Waste's 54-acre landfill facility located in Hernando, Florida, handles annual average disposals of roughly 240,000 cubic yards of construction debris annually. The site also offers an array of ancillary services such as roll-off dumpster services, mulching services and recycling. While the landfill facility is already permitted for future expansion, National Waste's growth strategy also calls for the opening of new satellite offices in counties and states that neighbor its existing operations.
In addition to increasing its geographic foothold, National Waste employs a strategic acquisition model to increase its overall market share. In 2015, the company acquired Gateway Rolloff Services LP and Waste Recovery Enterprises LLC, which are expected to generate a combined $3.8 million in annual revenue for National Waste moving forward. In the second quarter of 2016, National Waste added Sivart Services to its roster, creating an immediate source of additional revenue and expanding its foothold in the northeast area of New York.
Management has confirmed its interest in additional acquisition targets while demonstrating its ability to effectively integrate and organically grow the company's existing acquisition companies and maintain efficient operations. Disclaimer
National Waste Management Holdings, Inc. Company Blog
National Waste Management Holdings, Inc. News:
National Waste Management Holdings, Inc. (NWMH) Expands Market Reach in New York with Acquisition of Northeast Data Destruction and Recycling
National Waste Management Holdings, Inc. Ends Year on High Note, Announces Final Acquisition of 2016
NetworkNewsWire Releases Exclusive Audio Interview with National Waste Management Holdings, Inc. (NWMH)
GreenStone Healthcare Corp. (GRST)
The QualityStocks Daily Newsletter would like to spotlight GreenStone Healthcare Corp. (GRST). Today, GreenStone Healthcare Corp. closed trading at $0.057, up 14.00%, on 5,000 volume with 2 trades. The stock’s average daily volume over the past 60 days is 18,244, and its 52-week low/high is $0.015/$0.08.
GreenStone Healthcare Corp. (GRST), through its subsidiaries, provides medical services in the city of Toronto and the regional municipality of Muskoka, Ontario, Canada.
Located 90 minutes north of Toronto in Muskoka, GreenStone Healthcare's Addiction and Rehabilitation Treatments segment offers out-patient counseling, coaching, intervention, psychological assessment, and other related services.
GreeneStone Muskoka employs the best principles and practices currently available in the treatment of individuals with addiction. To ensure the most comprehensive and effective treatment for its clients, GreenStone Muskoka treats underlying or co-occurring disorders in tandem with the treatment of addiction.
The 36-bed addiction treatment center offers a holistic, individualized treatment approach to recovery. These private, paid programs vary in length from 45-90 days, depending on the unique needs of each resident and their response to the treatment.
GreenStone Muskoka also provides education and counseling sessions to educate the family members of its residents with the objective of helping them better understand the disease of addiction and how they should support their loved one throughout and after their recovery efforts.
GreenStone Healthcare President Shawn Leon has more than 25 years of experience managing public and private development-stage companies for various industries, including industrial minerals, aggregates, oil and gas, mining, financial, technology, hospitality and medical. He has provided financing and capital markets oversight for a number of these ventures, many of which have involved negotiations for mergers and acquisitions. He is joined by Vice President Dr. Anita Teslak, whose 25 years of combined experience as a CEO, psychologist and leadership provides valuable insight into a successful business model. Disclaimer
GreenStone Healthcare Corp. Company Blog
GreenStone Healthcare Corp. News:
GreeneStone Signs Definitive Agreement to Acquire Seastone of Delray, a Florida Limited Liability Company
GreeneStone Signs LOI to Acquire Aurora Recovery
GreeneStone Adds Two New Directors to the Board
GainClients, Inc. (GCLT)
The QualityStocks Daily Newsletter would like to spotlight GainClients, Inc. (GCLT). Today, GainClients, Inc. closed trading at $0.0287, up 13.89%, on 25,566 volume with 4 trades. The stock’s average daily volume over the past 60 days is 118,782, and its 52-week low/high is $0.01/$0.20.
GainClients, Inc. (GCLT) is a software service company focused primarily on the development of marketing services for real estate professionals and valuable home search and area information tools for consumers. The company's innovations expound the popularity of online networks by helping real estate professionals better serve their clients through the sharing of accurate real estate data.
The company's main product is the GCard progressive networking system, which is designed to build and promote relationships among real estate professionals and their clients. Using the GCard, agents and brokers have the means to offer real estate, lending and title services information through an integrated, web-based network, capitalizing on the ongoing shift in consumer preference toward mobile solutions.
Similar to the features of other popular online networks, professional users can invite clients and their industry partners to join their GCard networks and be featured as trusted team members. From here, the teams can quickly provide real estate, lending and title services and information to consumers via smartphone and web. With better communication throughout the process of buying or selling homes, purchases can move more quickly and more comfortably to completion.
Strategic partnerships are an important component of GainClients' growth strategy. The company recently established a worldwide licensing arrangement with CLOVIS LLC, a partnership that will enable the distribution of both companies' proprietary technologies to the real estate industry. CLOVIS will use GainClients' GCard to develop a unique lead generation program for the broader real estate marketing and advertising industry.
GainClients also offers GCHomeSearch, its stand-alone website that provides non-real estate customers, such as lenders and title professionals, with accurate listing data, historical property data, neighborhood information and demographics. When used with the GCard, the user is also privy to loan payment calculators, loan rates, closing cost estimators and other tools needed to make intelligent buying and selling choices. Disclaimer
GainClients, Inc. Company Blog
GainClients, Inc. News:
GainClients, Inc. Retains Largest Real Estate Customer on its GCard Service
GainClients, Inc. Announces Corporate Update
GainClients, Inc. Enters Into A Licensing Agreement with Real Estate Technology Upstart CLOVIS, LLC To Expand Its Technology Platform
Singlepoint, Inc. (SING)
The QualityStocks Daily Newsletter would like to spotlight Singlepoint, Inc. (SING). Today, Singlepoint, Inc. closed trading at $0.0407, up 4.36%, on 9,713,734 volume with 463 trades. The stock’s average daily volume over the past 60 days is 4,693,656, and its 52-week low/high is $0.0046/$0.0503.
Singlepoint, Inc. (SING) provides mobile technology and marketing solutions that enable companies, nonprofits and religious organizations to conduct business transactions, accept donations, and engage in targeted communication via mobile devices. Through diversification of its own model, the company is also leveraging its core technology to expand into the mobile auctions and daily fantasy sports markets.
SING currently has two fundraising solutions. Text2Bid is an interactive way to increase auction revenues. The technology makes it easy for people to bid in auctions from any text or web-enabled phone. Donate by Text allows nonprofits to securely collect one-time or recurring donations via text. This capability creates a personal experience for the donors, and enables ongoing communication between the donor and nonprofit or event sponsor.
SING's payment solutions include point-of-sale (POS) terminals, loyalty programs, payment processing, phone services and financing. Pay by Text™ enables a business to accept payment transactions and, in essence, turns the user's mobile phone into a point-of-sale device. Operating on the same platform as mobile marketing, Pay by Text is designed to increase revenues, raise the average per-transaction amount, and create a fast, easy and hassle-free method of payment.
As part of its diversification and expansion strategy, SING recently acquired an interest in DraftFury (www.draftfury.com), a company that offers skill-based NBA, NFL and MLB daily fantasy sports (DFS) contests. DraftFury is known for its innovative offerings and originality, and is the first cash-flow-positive DFS enterprise. This transaction places SING in a multi-billion dollar industry expected to generate entry fees of $14.4 billion in 2020. Under the guidance of a leadership team well-versed in technology, engineering, marketing and raising capital, SING anticipates a strong foothold in its chosen markets. Disclaimer
Singlepoint, Inc. Company Blog
Singlepoint, Inc. News:
SinglePoint, Inc. Signs LOI to Invest $800K in Jacksam Corp., Creator of Revolutionary Cannabis Technology
Singlepoint, Inc. Builds Its Payments Footprint in the Cannabis Industry -- CFN Media
Mounting Support for Marijuana Banking Has Widespread Implications
Today's Top 3
Promotion Stock Secrets
Profitable Trader Authority
The QualityStocks Public Company Sponsor News